drugset / Trial / NCT00468910

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

NCT00468910

Phase 2 Completed 79 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial is studying how well aspirin works in preventing colorectal cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.

Timeline

Start
2007-03
Primary completion
2009-12
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 325 mg Oral